Redesigned test introduces two new targets to improve coverage and sensitivity for Group B Streptococcus intrapartum testing for pregnant females Group B Streptococcus (GBS) is the leading cause of ...
Hosted on MSN
Nexsen accelerates US entry for rapid GBS test with FDA pre-submission and leadership boost
Nexsen Limited ( (AU:NXN)) has provided an announcement. Nexsen has lodged a pre-submission with the US Food and Drug Administration for its rapid Group B Streptococcus point-of-care diagnostic under ...
Group B Streptococcus, which people may call group B strep (GBS), is a type of bacterium that causes GBS disease. GBS can lead to meningitis, which is an infection of the lining of the brain and ...
Jane Plumb told ITV Meridian that change is needed from the government to help prevent the deaths of babies who come into ...
This study was approved by the Medical Ethics Committee of Qingdao Municipal Hospital (approval No. 2024-KY-035) and was conducted according to the guidelines of the Declaration of Helsinki. Written ...
SUNNYVALE, Calif., March 11, 2024 /PRNewswire/ -- Cepheid announced today that it has received clearance from the U.S. Food and Drug Administration for Xpert® Xpress GBS, a dual-target molecular ...
Redesigned test introduces two new targets to improve coverage and sensitivity for Group B Streptococcus intrapartum testing for pregnant females With the capability of returning positive results as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results